Last reviewed · How we verify
NCT05232019
Association Between Embryo Implantation Rate and Maternal Age
trial in Infertility, Female in 17,394 participants. Completed in 31 December 2020.
31 December 2019
Quick facts
| Lead sponsor | Nanjing University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 17,394 |
| Start date | 1 January 2015 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across China |
Conditions studied
- Infertility, Female — all drugs for Infertility, Female →
Sponsor
Nanjing University
Who can join
Adults 20 to 50, female only, with Infertility, Female. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To explore the relationship between maternal age and embryo implantation rate in patients undergoing assisted reproductive technology.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05232019
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility, Female
Currently open trials in the same condition.
- NCT06771401 — Identification of Biomarkers in Cervical Mucus · NA · recruiting
- NCT06984081 — CAPA In-vitro Oocyte Maturation · NA · recruiting
- NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
- NCT07175571 — SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques · NA · recruiting
- NCT06193135 — Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitar · NA · recruiting
Other Nanjing University trials
Trials by the same sponsor.
- NCT06571214 — Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment · Phase 4 · not yet recruiting
- NCT07128394 — Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment · NA · recruiting
- NCT06477211 — DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma · completed
- NCT06005207 — Vaginal Progesterone Improves Clinical Outcomes of RIF Patients · NA · unknown
- NCT06174597 — Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05232019 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nanjing University
- Last refreshed: 22 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05232019.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing